Strides Pharma Science Ltd. Financials: Quarterly Results
Revenue
1247.97
Cr.
PAT
132.57
Cr.
EBITDA
209.06
Cr.
Strides Pharma Science Ltd. Q1FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 1220.83 | 1119.74 | 1190.39 | 1153.67 | 1201.11 |
| Total Income From Operations (Cr.) | 1220.83 | 1119.74 | 1190.39 | 1153.67 | 1201.11 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 209.06 | 177.77 | 180.99 | 167.50 | 213.69 |
| P/L Before Exceptional Items & Tax (Cr.) | 162.94 | 130.31 | 130.67 | 115.32 | 131.55 |
| P/L After Tax from Ordinary Activities (Cr.) | 132.57 | 105.49 | 82.49 | 89.09 | 106.47 |
| Net Profit/Loss For the Period (Cr.) | 132.57 | 105.49 | 82.49 | 89.09 | 106.47 |
| Basic EPS | 13.84 | 10.81 | 8.92 | 9.56 | 10.14 |
FAQs
Strides Pharma Science Ltd. announced its quarterly results for Q1 FY2026 on July 29, 2025.
In Q1 FY2026, Strides Pharma Science Ltd. are as follows:
Revenue: ₹1247.97 crore
Net Profit: ₹132.57 crore.
For Q1 FY2026, Strides Pharma Science Ltd. posted ₹1247.97 crore in revenue and ₹132.57 crore in net profit.
Past quarterly results for Strides Pharma Science Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.